Terns Pharmaceuticals Inc

NASDAQ:TERN   10:06:06 AM EDT
9.87
+0.07 (+0.71%)
Earnings Announcements

Terns Reports Fourth Quarter And Full Year 2020 Financial Results

Published: 03/30/2021 20:36 GMT
Terns Pharmaceuticals Inc (TERN) - Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update.
Terns Pharmaceuticals Inc Quarterly Loss per Share $3.65.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.